LYZ1 Stock Overview
A venture capital firm specializing in early stage investments. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Seed Innovations Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | UK£0.007 |
52 Week High | UK£0.007 |
52 Week Low | UK£0.007 |
Beta | 0.79 |
11 Month Change | n/a |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 0% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
LYZ1 | DE Capital Markets | DE Market | |
---|---|---|---|
7D | n/a | -1.1% | 0.2% |
1Y | n/a | 26.5% | 8.5% |
Return vs Industry: Insufficient data to determine how LYZ1 performed against the German Capital Markets industry.
Return vs Market: Insufficient data to determine how LYZ1 performed against the German Market.
Price Volatility
LYZ1 volatility | |
---|---|
LYZ1 Average Weekly Movement | n/a |
Capital Markets Industry Average Movement | 4.2% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.9% |
10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: LYZ1's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: Insufficient data to determine LYZ1's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Ed McDermott | www.seedinnovations.co |
Seed Innovations Limited, is a venture capital firm specializing in early stage investments. The firm prefers to focus on investments in innovative lifestyle, wellness, health, medical cannabis, technology, life sciences, biotech, food science, blockchain technology, longevity of life, pharmaceuticals, artificial intelligence and digital delivery. It typically invests in North America and Europe but will consider investments elsewhere in the world.
Seed Innovations Limited Fundamentals Summary
LYZ1 fundamental statistics | |
---|---|
Market cap | €3.60m |
Earnings (TTM) | -€2.55m |
Revenue (TTM) | n/a |
-2.7x
P/S Ratio-1.4x
P/E RatioIs LYZ1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
LYZ1 income statement (TTM) | |
---|---|
Revenue | -UK£1.10m |
Cost of Revenue | UK£108.00k |
Gross Profit | -UK£1.21m |
Other Expenses | UK£907.00k |
Earnings | -UK£2.12m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.011 |
Gross Margin | 109.77% |
Net Profit Margin | 191.86% |
Debt/Equity Ratio | 0% |
How did LYZ1 perform over the long term?
See historical performance and comparison